Medius Holdings Co., Ltd. (TYO:3154)
966.00
-7.00 (-0.72%)
Jun 9, 2025, 2:36 PM JST
Medius Holdings Revenue
Medius Holdings had revenue of 76.81B JPY in the quarter ending March 31, 2025, with 15.67% growth. This brings the company's revenue in the last twelve months to 286.18B, up 14.12% year-over-year. In the fiscal year ending June 30, 2024, Medius Holdings had annual revenue of 259.79B with 8.67% growth.
Revenue (ttm)
286.18B
Revenue Growth
+14.12%
P/S Ratio
0.08
Revenue / Employee
113.70M
Employees
2,517
Market Cap
21.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 259.79B | 20.74B | 8.67% |
Jun 30, 2023 | 239.05B | 12.45B | 5.49% |
Jun 30, 2022 | 226.61B | -20.18B | -8.18% |
Jun 30, 2021 | 246.79B | 36.40B | 17.30% |
Jun 30, 2020 | 210.39B | 12.70B | 6.42% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |